Back to mobile site
Get it on Google Play

Innovent's mazdutide outperforms semaglutide in diabetes trial

October 26, 2025 8:00 PM EDT Send to a Friend
Innovent Biologics Inc. (HKEX: 01801) reported that its drug mazdutide demonstrated superior effectiveness compared to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login